Free Trial

Provectus Biopharmaceuticals (PVCT) SEC Filings & 10K Form

Provectus Biopharmaceuticals logo
$0.07 0.00 (-0.27%)
As of 07/18/2025 02:18 PM Eastern

Recent Provectus Biopharmaceuticals SEC Filings

DateFilerForm TypeView
06/26/2025
11:36 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
1:47 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
5:15 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:42 AM
Provectus Biopharmaceuticals (Filer)
Form DEFA14A
06/18/2025
7:43 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
5:24 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
3:32 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
1:24 PM
Provectus Biopharmaceuticals (Filer)
Form 10-K/A
05/15/2025
8:09 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
8:46 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:14 AM
Provectus Biopharmaceuticals (Filer)
Form ARS
04/30/2025
10:38 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
1:22 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
12:35 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
2:13 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
6:20 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
7:37 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:47 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:26 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
10:10 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
12:37 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:13 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
2:57 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
12:31 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:33 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:30 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
8:00 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
6:45 PM
Pershing Edward (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13D/A
12/02/2024
6:48 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:12 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
7:00 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
11:31 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:58 PM
Bailey Webster (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:01 PM
Lacey John III (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:06 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:56 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:58 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
4:21 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
8:54 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
10:15 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)

Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.

We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
08/19/2024
2:06 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:23 PM
Morris Jeffrey Allen (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13G
08/14/2024
6:19 PM
Morris Jeffrey Allen (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
12:21 PM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
2:31 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
4:20 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:24 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
12:02 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:PVCT) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners